Technical Insights on Medical Equipment Wholesale Stocks -- Henry Schein, Patterson, Owens & Minor, and PharMerica

NEW YORK, September 14, 2017 /PRNewswire/ --

If you want a Stock Review on HSIC, PDCO, OMI, or PMC then come over to and sign up for your free customized report today. On Wednesday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the trading session up 0.09%; the Dow Jones Industrial Average edged 0.18% higher; and the S&P 500 was up 0.08%. US markets saw four out of nine sectors finishing the day in red, 3 in green, and 2 in neutral territory. Pre-market today, reviews these four Medical Equipment Wholesale stocks: Henry Schein Inc. (NASDAQ: HSIC), Patterson Cos. Inc. (NASDAQ: PDCO), Owens & Minor Inc. (NYSE: OMI), and PharMerica Corp. (NYSE: PMC). Access's free research reports for this morning's stocks line-up at:

Henry Schein 

Melville, New York headquartered Henry Schein Inc.'s stock finished Wednesday's session 4.00% lower at $168.88. A total volume of 1.13 million shares was traded, which was above its three months average of 444.54 thousand shares. The Company's shares have advanced 11.32% on an YTD basis. The stock is trading below its 50-day moving average by 4.67%. Furthermore, shares of Henry Schein, which provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide, have a Relative Strength Index (RSI) of 39.34. Free research report on HSIC is available at:

Patterson Cos. 

Shares in St. Paul, Minnesota headquartered Patterson Cos. Inc. ended at $39.44, down 2.98% from the last trading session. The stock recorded a trading volume of 1.82 million shares, which was above its three months average volume of 1.26 million shares. The Company's shares have gained 4.06% in the last one month. The stock is trading below its 50-day moving average by 2.28%. Moreover, shares of Patterson Cos., which distributes and sells dental and animal health products in the US, the UK, and Canada, have an RSI of 52.58.

On August 15th, 2017, research firm Stifel reiterated its 'Sell' rating on the Company's stock with a decrease of the target price from $39 a share to $34 a share. The complimentary research report on PDCO can be downloaded at:

Owens & Minor 

Mechanicsville, Virginia headquartered Owens & Minor Inc.'s stock ended yesterday's session 1.25% lower at $28.48 with a total trading volume of 711,274 shares, which was above its three months average of 680.38 thousand shares. The Company's shares have advanced 1.35% in the past month. The stock is trading below its 50-day moving average by 4.22%. Additionally, shares of Owens & Minor, which together with its subsidiaries, operates as a healthcare services company in the US, the UK, Ireland, France, Germany, and other European countries, have an RSI of 48.67.

On September 01st, 2017, research firm Robert W. Baird upgraded the Company's stock rating from 'Underperform' to 'Neutral', with a target price of $28 per share. Visit us today and access our complete research report on OMI at:


On Wednesday, shares in Louisville, Kentucky headquartered PharMerica Corp. recorded a trading volume of 810,440 shares, which was above their three months average volume of 452.57 thousand shares. The stock finished the day 0.69% higher at $29.15. The Company's shares have advanced 12.33% in the previous three months and 15.90% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 5.16% and 14.54%, respectively. Furthermore, shares of PharMerica, which operates as an institutional pharmacy services company in the US, have an RSI of 63.13. Get free access to your research report on PMC at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.